Eduardo López-Ortiz

Dr. Eduardo López-Ortiz


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2022 in Life
Verified
Journal Article
Open access
PDF file
IPIndira Rocio Mendiola Pastrana
Indira Rocio Mendiola Pastrana
ELEduardo López-Ortiz
Eduardo López-Ortiz
JLJosé G. Río de la Loza-Zamora
José G. Río de la Loza-Zamora
JGJames González
James González
AGAnel Gomez Garcia
Anel Gomez Garcia
GLGeovani Lopez-Ortiz
Geovani Lopez-Ortiz
Background: From the start of the COVID-19 pandemic, new SARS-CoV-2 variants have emerged that potentially affect transmissibility, severity, and immune evasion in infected individuals. In the present systematic review, the impact of different SARS-CoV-2 variants on clinical outcomes is analyzed. Methods: A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020. Two databases (PubMed and ScienceDirect) were searched for original articles published from 1 January 2020 to 23 November 2021. The articles that met the selection criteria were appraised according to the Newcastle–Ottawa Quality Assessment Scale. Results: Thirty-three articles were included, involving a total of 253,209 patients and 188,944 partial or complete SARS-CoV-2 sequences. The most reported SARS-CoV-2 variants showed changes in the spike protein, N protein, RdRp and NSP3. In 28 scenarios, SARS-CoV-2 variants were found to be associated with a mild to severe or even fatal clinical outcome, 15 articles reported such association to be statistically significant. Adjustments in eight of them were made for age, sex and other covariates. Conclusions: SARS-CoV-2 variants can potentially have an impact on clinical outcomes; future studies focused on this topic should consider several covariates that influence the clinical course of the disease.

27 September 2024 in Publications
Verified
Journal Article
Open access
PDF file
IPIndira Rocio Mendiola Pastrana
Indira Rocio Mendiola Pastrana
ELEduardo López-Ortiz
Eduardo López-Ortiz
RHRubí G. Hernández-López
Rubí G. Hernández-López
FRFernanda Romero
Fernanda Romero
RDRocío Dávila-Mendoza
Rocío Dávila-Mendoza
GLGeovani Lopez-Ortiz
Geovani Lopez-Ortiz
Objective: This paper aims to evaluate the quality of scientific production in family medicine in Mexico and identify gaps in the development of research in this medical discipline. Methods: This cross-sectional study analyzed original articles, reviews, case reports, and editorials published from Mexico, from the year 2014 to 2023, in the three family medicine journals edited in the country. Several bibliometric indicators were evaluated. Attributes that confer validity in original articles were analyzed, and through random sampling, 10% were selected to determine their quality using checklists. Results: A total of 627 articles were analyzed; among these, 57.89% were original, 19.61% reviews, 17.06% editorials, and 5.42% case reports. Our analysis revealed significant disparities in research activity across regions in Mexico. Productivity, transience, and isolation indices were 2.79, 78.58%, and 54.05%, respectively, while the Price index was 42.74%. A small percentage of articles received funding and followed guidelines for medical research reporting (0.47% and 0.63%, respectively). The analysis of validity attributes in original articles revealed that 92.83% were observational, 88.98% were unicentric, in 47.38%, no sample size calculation was performed or specified, while in 12.12%, sampling was probabilistic. In the evaluation of the original articles, more than 60% showed limitations that compromised their quality. Conclusions: The number of published articles, along with their bibliometric, validity, and quality attributes, reflect significant gaps in the generation and dissemination of knowledge in family medicine in Mexico. This shows a transgenerational problem, identified in many countries, where the advancement of family medicine as a specialty is limited by low research productivity and methodological weaknesses in reporting.

3 May 2021 in Medicina
Verified
Journal Article
Open access
PDF file
BOBRENDA GARDUÑO ORBE
BRENDA GARDUÑO ORBE
JSJuan Manuel Sánchez-Rebolledo
Juan Manuel Sánchez-Rebolledo
MCMustafá Cortés-Rafael
Mustafá Cortés-Rafael
YGYuliana García-Jiménez
Yuliana García-Jiménez
MPMarcelina Perez-Ortiz
Marcelina Perez-Ortiz
GLGeovani Lopez-Ortiz
Geovani Lopez-Ortiz
Since the onset of the COVID-19 pandemic, there have been multiple questions regarding reinfections associated with SARS-CoV-2. Healthcare workers on duty, due to overexposure in environments where there are more cases of COVID-19, are more prone to become infected by this virus. Here, we report 4 cases that meet the definition of clinical reinfection by SARS-CoV-2, as well as a literature review on this subject; all occurred in healthcare workers in Acapulco Guerrero, Mexico who provide their services in a hospital that cares for patients with COVID-19. The time between the manifestation of the first and second infection for each case was 134, 129, 107 and 82 days, all patients presented symptomatology in both events. The time between remission of the first infection and onset of second infection was 108, 109, 78 and 67 days for each case, while the time to confirmation by reverse transcription polymerase chain reaction (RT-PCR) between infections was 134, 124, 106 and 77 days. In two of the four cases the reinfection resulted in a more severe case, while in the remaining two cases the manifestation of symptoms and complications was similar to that presented in the first infection. Given this scenario, greater care is needed in the management of the pandemic caused by SARS-CoV-2 to protect healthcare workers and the general public from risks and complications caused by a possible reinfection by SARS-CoV-2.

ELEduardo López-Ortiz
Eduardo López-Ortiz
JAJuan Manuel Altamirano
Juan Manuel Altamirano
FRFernanda Romero
Fernanda Romero
GLGeovani Lopez-Ortiz
Geovani Lopez-Ortiz
Background: In Mexico, homicides are the leading cause of death among men aged 15 to 44 years; however, despite their increase in recent decades, the study of this issue is insufficient, given its magnitude and impact. Therefore, this study aimed to characterize the spatial and temporal patterns and associated factors of homicides in Mexico from 2015 to 2022. Methods: An analytical cross-sectional study was conducted, analyzing death records from the National Institute of Statistics and Geography’s general mortality databases. Simple frequencies and incidence rates per 100,000 inhabitants by sex, year, and state of the Mexican Republic were calculated. Mortality was evaluated by age groups and geographic areas, and bivariate logistic regression models with sociodemographic variables were performed. Results: Records of 229,182 homicides in Mexico were analyzed, with a median age of 33 years, interquartile range 18. A total of 203,898 (88.96%) were men and 25,284 (11.04%) were women. The majority of deaths occurred in public places and were caused by firearms; women had a higher percentage of homicides at home. States with high incidence rates for both sexes were Chihuahua, Zacatecas, Michoacán, Colima, and Estado de México. The total years of life lost were 9.19 million years. The national incidence of homicides in men showed an upward trend from 2015 to 2019; however, in the case of women, this incidence increased in various age groups during the study period. Occupation, education, marital status, and place of occurrence had significant associations in the logistic regression models. Conclusions: This study provides a spatial-temporal characterization of homicides in Mexico between 2015 and 2022, highlighting the high incidence in men and the upward trend in certain age groups among women. These findings underscore the need for preventive measures and public policies to address this issue in a multisectoral manner.